These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15082424)

  • 21. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 23. [The BAFTA study].
    Di Pasquale G; Palareti G
    G Ital Cardiol (Rome); 2008 Nov; 9(11):735-9. PubMed ID: 19058663
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 26. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 27. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 29. Atrial fibrillation and stroke prevention.
    Kakar P; Lip GY
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation.
    Ebell MH
    Am Fam Physician; 2005 Jun; 71(12):2348-50. PubMed ID: 15999873
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithrombotic agents in cerebral ischaemia.
    Dalal PM; Mishra NK; Bhattacharjee M; Bhat P
    J Assoc Physicians India; 2006 Jul; 54():555-61. PubMed ID: 17089906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Patent foramen ovale and stroke].
    Mono ML; Nedeltchev K
    Fortschr Neurol Psychiatr; 2012 May; 80(5):288-99. PubMed ID: 22566139
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
    Beckman JA
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 37. [Secondary prevention of stroke].
    Shinohara Y
    No To Shinkei; 2004 Nov; 56(11):933-9. PubMed ID: 15678950
    [No Abstract]   [Full Text] [Related]  

  • 38. FPIN's clinical inquiries. Warfarin for prevention of ischemic stroke recurrence?
    Lo V; Noviasky J; Nashelsky J
    Am Fam Physician; 2006 Jun; 73(11):2011-2. PubMed ID: 16770933
    [No Abstract]   [Full Text] [Related]  

  • 39. Warfarin versus aspirin for stroke prevention (BAFTA).
    Diug B; Lowthian J; Evans S
    Lancet; 2007 Nov; 370(9599):1606; author reply 1606-7. PubMed ID: 17993355
    [No Abstract]   [Full Text] [Related]  

  • 40. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
    Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
    J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.